{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:05:05Z","timestamp":1770959105073,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T00:00:00Z","timestamp":1177545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2334-7-34","type":"journal-article","created":{"date-parts":[[2007,4,30]],"date-time":"2007-04-30T11:56:56Z","timestamp":1177934216000},"source":"Crossref","is-referenced-by-count":4,"title":["Failure of recombinant factor VIIa in a patient with severe polymicrobial sepsis and postoperative uncontrolled intraabdominal bleeding"],"prefix":"10.1186","volume":"7","author":[{"given":"Anna","family":"Conen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios A","family":"Tsakiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Siegemund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,26]]},"reference":[{"issue":"8621","key":"477_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","volume":"2","author":"U Hedner","year":"1988","unstructured":"Hedner U, Glazer S, Pingel K, Alberts KA, Blomback M, Schulman S, Johnsson H: Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet. 1988, 2 (8621): 1193-10.1016\/S0140-6736(88)90259-0.","journal-title":"Lancet"},{"issue":"3","key":"477_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ajh.2830320315","volume":"32","author":"BG Macik","year":"1989","unstructured":"Macik BG, Hohneker J, Roberts HR, Griffin AM: Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor. Am J Hematol. 1989, 32 (3): 232-234. 10.1002\/ajh.2830320315.","journal-title":"Am J Hematol"},{"issue":"3","key":"477_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00001721-199008000-00009","volume":"1","author":"U Hedner","year":"1990","unstructured":"Hedner U: Factor VIIa in the treatment of haemophilia. Blood Coagul Fibrinolysis. 1990, 1 (3): 307-317.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"477_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.blre.2003.12.003","volume":"18","author":"S Ghorashian","year":"2004","unstructured":"Ghorashian S, Hunt BJ: \"Off-license\" use of recombinant activated factor VII. Blood Rev. 2004, 18 (4): 245-259. 10.1016\/j.blre.2003.12.003.","journal-title":"Blood Rev"},{"key":"477_CR5","volume-title":"Off-label-Indikation von rekombinantem aktiviertem Faktor VII (rFVIIa, NovoSeven\u00ae), issued by Swiss Society for Intensive Care Medicine","author":"R Paganoni","year":"2005","unstructured":"Paganoni R: Off-label-Indikation von rekombinantem aktiviertem Faktor VII (rFVIIa, NovoSeven\u00ae), issued by Swiss Society for Intensive Care Medicine. 2005, www.swiss-icu.ch\/NovoSeven_V07.pdf"},{"issue":"4","key":"477_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1538-7836.2005.01203.x","volume":"3","author":"U Martinowitz","year":"2005","unstructured":"Martinowitz U, Michaelson M: Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost. 2005, 3 (4): 640-648. 10.1111\/j.1538-7836.2005.01203.x.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"477_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa042991","volume":"352","author":"SA Mayer","year":"2005","unstructured":"Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005, 352 (8): 777-785. 10.1056\/NEJMoa042991.","journal-title":"N Engl J Med"},{"issue":"1","key":"477_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","volume":"59","author":"KD Boffard","year":"2005","unstructured":"Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005, 59 (1): 8-15; discussion 15-8.","journal-title":"J Trauma"},{"issue":"9","key":"477_CR9","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/j.1538-7836.2005.01523.x","volume":"3","author":"M Pihusch","year":"2005","unstructured":"Pihusch M, Bacigalupo A, Szer J, von Depka Prondzinski M, Gaspar-Blaudschun B, Hyveled L, Brenner B: Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost. 2005, 3 (9): 1935-1944. 10.1111\/j.1538-7836.2005.01523.x.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"477_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/lt.20458","volume":"11","author":"RM Planinsic","year":"2005","unstructured":"Planinsic RM, van der Meer J, Testa G, Grande L, Candela A, Porte RJ, Ghobrial RM, Isoniemi H, Schelde PB, Erhardtsen E, Klintmalm G, Emre S: Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl. 2005, 11 (8): 895-900. 10.1002\/lt.20458.","journal-title":"Liver Transpl"},{"key":"477_CR11","first-page":"102","volume":"26 Suppl 1","author":"U Hedner","year":"1996","unstructured":"Hedner U: Dosing and monitoring NovoSeven treatment. Haemostasis. 1996, 26 Suppl 1: 102-108.","journal-title":"Haemostasis"},{"issue":"3","key":"477_CR12","first-page":"609","volume":"59","author":"DM Stein","year":"2005","unstructured":"Stein DM, Dutton RP, O'Connor J, Alexander M, Scalea TM: Determinants of Futility of Administration of Recombinant Factor VIIa in Trauma. J Trauma. 2005, 59 (3): 609-615.","journal-title":"J Trauma"},{"issue":"5","key":"477_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/01.TA.0000066184.20808.A5","volume":"55","author":"ZH Meng","year":"2003","unstructured":"Meng ZH, Wolberg AS, Monroe DM, Hoffman M: The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma. 2003, 55 (5): 886-891.","journal-title":"J Trauma"},{"issue":"2","key":"477_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.0042-9007.2004.00393.x","volume":"86","author":"AD Clark","year":"2004","unstructured":"Clark AD, Gordon WC, Walker ID, Tait RC: 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang. 2004, 86 (2): 120-124. 10.1111\/j.0042-9007.2004.00393.x.","journal-title":"Vox Sang"},{"issue":"3","key":"477_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ccc.2005.02.001","volume":"21","author":"M Levi","year":"2005","unstructured":"Levi M: Disseminated intravascular coagulation: What's new?. Crit Care Clin. 2005, 21 (3): 449-467. 10.1016\/j.ccc.2005.02.001.","journal-title":"Crit Care Clin"},{"issue":"1","key":"477_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","volume":"114","author":"F Moscardo","year":"2001","unstructured":"Moscardo F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA: Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 2001, 114 (1): 174-176. 10.1046\/j.1365-2141.2001.02878.x.","journal-title":"Br J Haematol"},{"issue":"4","key":"477_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.mbc.0000169224.23550.3f","volume":"16","author":"J Martinez","year":"2005","unstructured":"Martinez J, Cid AR, de la Rubia J, Gimeno R: Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock. Blood Coagul Fibrinolysis. 2005, 16 (4): 297-299.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"477_CR18","first-page":"577","volume":"15","author":"S Sallah","year":"2004","unstructured":"Sallah S, Husain A, Nguyen NP: Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2004, 15 (7): 577-582.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"477_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-9560-4-1","volume":"4","author":"P Eller","year":"2006","unstructured":"Eller P, Pechlaner C, Wiedermann CJ: Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation-related gastrointestinal bleeding. Thromb J. 2006, 4 (1): 1-10.1186\/1477-9560-4-1.","journal-title":"Thromb J"},{"issue":"4","key":"477_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/01.CCM.0000159087.85970.38","volume":"33","author":"M Levi","year":"2005","unstructured":"Levi M, Peters M, Buller HR: Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med. 2005, 33 (4): 883-890. 10.1097\/01.CCM.0000159087.85970.38.","journal-title":"Crit Care Med"},{"issue":"3","key":"477_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jama.295.3.293","volume":"295","author":"KA O'Connell","year":"2006","unstructured":"O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM: Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. Jama. 2006, 295 (3): 293-298. 10.1001\/jama.295.3.293.","journal-title":"Jama"},{"key":"477_CR22","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1186\/cc3781","volume":"9 Suppl 5","author":"AE Pusateri","year":"2005","unstructured":"Pusateri AE, Park MS: Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma. Crit Care. 2005, 9 Suppl 5: S15-24. 10.1186\/cc3781.","journal-title":"Crit Care"},{"key":"477_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2516.2005.01156.x","volume":"11 Suppl 1","author":"B Sorensen","year":"2005","unstructured":"Sorensen B, Ingerslev J: Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia. 2005, 11 Suppl 1: 1-6. 10.1111\/j.1365-2516.2005.01156.x.","journal-title":"Haemophilia"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-34\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T23:48:06Z","timestamp":1548200886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-34","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,26]]},"article-number":"34"}}